The Beachbody Company, Inc.

Investors should consider buying shares of micro-cap fitness and nutrition company the <a href="https://thebeachbodycompany.com/overview/default.aspx">Beachbody Company</a>, which has upside of almost 150%, Noble Capital Markets <a href="https://dashboard.channelchek.com/wp-content/uploads/pdf/BODI_20251028_27773.pdf">said</a>&nbsp;in an initiation report. After several years of declining revenue, analysts believe the company is on the cusp of recovery, helped in part by the "current GLP-1 phenomenon."

Noble initiates on Beachbody Company with 'buy' as beneficiary of 'GLP-1 phenomenon'

Crocs, Inc.

Footwear manufacturer Crocs reported the first decline in sales of its flagship brand in five years. Its third-quarter revenue fell 2.5% to $836 million, the company said in its financial <a href="https://investors.crocs.com/news-and-events/press-releases/press-release-details/2025/Crocs-Inc--Reports-Third-Quarter-2025-Results/default.aspx">report</a> released Oct. 30. This is the first negative result since the second quarter of 2020,<a href="https://www.marketwatch.com/story/has-crocs-demand-peaked-sales-just-dropped-and-are-expected-to-keep-falling-8d5a5e37?mod=newsviewer_click_seemore">writes</a> MarketWatch. In the current quarter, the company also expects sales of the Crocs brand to fall by about 3%.

Footwear brand Crocs has its first drop in sales in five years. What's happening to the company?

Absci Corporation

Applied Digital Corporation

Innodata Inc.

Relay Therapeutics, Inc.

For small-cap stocks, the end of summer was a turning point. At a symposium in Jackson Hole, Fed Chairman Jerome Powell signaled that the monetary tightening cycle was coming to an end. For small-caps, whose profitability is particularly dependent on borrowing costs, this signaled a revision of expectations. Additional impetus came from the technology sector: a rise in new contracts to build AI data centers and strong demand for products from market leaders Nvidia, Oracle and TSMC reinforced investors' belief that even small tech companies can benefit from the ongoing AI boom.

The tidal effect: how tech small-caps grew in the third quarter

Victoria's Secret & Co.

UBS has <a href="https://seekingalpha.com/news/4510219-victorias-secret-rallies-after-ubs-pitches-the-bull-case">upgraded</a>&nbsp;Victoria’s Secret, one of the world’s best-known lingerie retailers, to “buy,” saying the management is capable of restoring sustainable growth after several years of declining sales. The bank’s target price offers 27% upside.

UBS upgrades Victoria’s Secret to 'buy' on growing conviction in management

Viking Therapeutics, Inc.

Novo Nordisk A/S

Eli Lilly and Company

Shares of biotech company Viking Therapeutics could triple, according to Canaccord Genuity, which in a <a href="https://www.cnbc.com/2025/10/29/biggest-analyst-calls-wednesday-include-nvidia-apple-tesla-datadog.html">coverage initiation</a> called the firm "one of the leading biotech companies in the obesity drug development space," now <a href="https://oninvest.com/article/gde-investoram-iskat-potencial-nyj-hit-na-rynke-preparatov-ot-lisnego-vesa">dominated</a>&nbsp;by Novo Nordisk and Eli Lilly.

Canaccord initiates on obesity drugmaker Viking with 'buy,' sees 200% upside

Douglas Dynamics, Inc.

Freedom Broker recommends clients buy shares of Douglas Dynamics, a small manufacturer of snow-clearing equipment whose stock is up more than 30% year to date. The target price set for Douglas securities is 20% above current quotes. Sustainable growth is supported by well-known brands, a wide dealer network, and a balanced sales structure, analysts say.

Freedom initiates on snowplow maker Douglas with 'buy,' TP implying 20% upside

Zedge, Inc.

Shares of Zedge, a micro-cap company that created an emoji encyclopedia and sells ringtones and wallpapers for cell phones, plummeted more than 24% yesterday, October 28. Investors reacted to the company’s fourth-quarter and fiscal-full-year <a href="https://feeds.issuerdirect.com/news-release.html?newsid=7206297427461208&amp;symbol=ZDGE">earnings</a>, with declines across all key financial indicators. The selloff was not tempered by promises about 2026 as "a year of innovation focused on unlocking growth."

Emoji encyclopedia owner Zedge plunges 24% on disappointing fiscal-2025 results

Serve Robotics Inc.

Symbotic Inc.

NIO Inc.

Motley Fool analyst Leo Sun has <a href="https://www.fool.com/investing/2025/10/28/growth-stocks-that-could-be-10-baggers-in-10-years/">highlighted</a>&nbsp;three undervalued stocks that, in his view, could deliver tenfold returns over the next decade. One of them is small-cap company Serve Robotics, a developer of autonomous delivery robots. The other two are warehouse-automation firm Symbotic and Chinese EV maker Nio.

Motley Fool names three growth stocks with 10x upside over a decade

Avidity Biosciences, Inc.

Novartis AG

Shares of Avidity Biosciences, a small developer of therapies for rare diseases including Duchenne muscular dystrophy, jumped more than 40% yesterday, October 27, to an all-time high. Investors reacted to news that Switzerland’s Novartis <a href="https://www.prnewswire.com/news-releases/avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis-ag-302594703.html">plans</a>&nbsp;to acquire the company at a premium to the market. The move sends a signal to investors in small-cap biotech: pharma majors increasingly prefer to buy externally developed assets rather than build them in-house. More transactions can be expected in the coming months, Noble Capital Markets <a href="https://www.channelchek.com/news-channel/novartis-12-billion-avidity-acquisition-strengthens-its-rare-disease-pipeline-amid-pharma-tariff-uncertainty">said</a>&nbsp;in a post.

Novartis $12 bln deal for Avidity sparks mid-cap biotech rally


Unitil Corporation

Global Water Resources, Inc.

Sky Harbour Group Corporation

Millrose Properties, Inc.

Industrial Logistics Properties Trust

The Fed will announce its interest-rate decision on Wednesday, October 29. Markets <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">expect</a>&nbsp;a 25-basis-point cut to 3.75-4.00%. The prior revision in September reignited the stock market, and analysts <a href="https://en.oninvest.com/article/russell-2000-is-clear-winner-from-fed-rate-cut-reaches-new-all-time-high">called</a>&nbsp;small-caps – represented by the Russell 2000 index – the “clear winner.” The day after the decision, on September 18, the index hit a new all-time high for the first time in four years, jumping 2%. Over the last six months, the <a href="https://finance.yahoo.com/quote/%5ERUT/">Russell 2000</a>&nbsp;is up 28.4%, outpacing the <a href="https://finance.yahoo.com/quote/%5ESPX/">S&amp;P 500</a>, the benchmark for large caps, which is up 23.8% in the same period.

Freedom picks small caps set to gain from another Fed rate cut

Beyond Meat, Inc.

Alector, Inc.

Freedom Broker has pointed out the two small-cap stocks with the most pronounced moves last week (October 20-24). The outperformer was plant-based meat producer Beyond Meat, while the underperformer was biopharma company Alector, a developer of therapies for dementia.

Freedom Broker names biggest small cap outperformer and underperformer from last week

Twin Hospitality Group Inc.

The fair value of shares of small-cap restaurant operator Twin Hospitality Group is $10 apiece, or 154% above <a href="https://finance.yahoo.com/quote/TWNP/">current quotes</a>, Noble Capital Markets estimates in a <a href="https://dashboard.channelchek.com/wp-content/uploads/pdf/TWNP_20251021_27732.pdf">coverage initiation report</a> on the company. The analysts say the company has considerable scope to expand, both by adding new restaurants and by tightening operations.

#Small caps: 752